BKD vs TLX: Which Stock Is the Better Buy?
Brookdale Senior Living Inc. and Telix Pharmaceuticals Limited side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — BKD vs TLX, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Brookdale Senior Living Inc. (BKD) | Telix Pharmaceuticals Limited (TLX) | |
|---|---|---|
| Market cap | $3.2B | $3.2B |
| Revenue (latest FY) | $3.19B | $803.79M |
| Net income (latest FY) | $-262.69M | $-7.13M |
| Revenue growth (5y CAGR) | -2.0% | 94.7% |
| Net margin | -8.2% | -0.9% |
| Return on equity | 587.0% | -1.7% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 2 |
| Positive free cash flow | Yes | — |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full BKD vs TLX breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BKD's full financials → Open TLX's full financials →More comparisons
Frequently asked questions
Which is bigger, BKD or TLX?
Telix Pharmaceuticals Limited is larger by market capitalization — $3.2B versus $3.2B.
Which grows faster, BKD or TLX?
Over the last five fiscal years, Telix Pharmaceuticals Limited grew revenue faster — 94.7%/yr versus -2.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.